Telos Biotech and Made Scientific Partner to Advance TELOVANCEâ„¢ Evaluation
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
BOSTON, Mass., May 8, 2026 Ensoma announced the presentation of initial clinical safety data from the first participant dosed...
